Maxime Dely: The Lifesaving Power of Plasma Donations
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post onย LinkedIn:
”Plasma matters more than we think.
With this 3rd donation of the year, the goal of 10 donations in 2026 remains well on track.
Beyond the gesture itself, each donation helps collect valuable components used every day in medicine.
Among them, fibrinogen plays a central role: this protein is directly involved in blood clotting, transforming into fibrin, which is essential for forming the clot that helps stop bleeding.
Without sufficient fibrinogen, certain medical procedures become far more complex, especially in cases of surgery, trauma, or specific coagulation disorders.
Donating plasma means contributing directly to an essential care chain โ often invisible, yet vital for many patients.
A simple, regular, and meaningful contribution.”
Stay updated withย Hemostasis Today.
-
Sep 8, 2026, 11:15Andreas Tridimas: Atherosclerosis Is Greyer Than We Admit
-
Sep 8, 2026, 10:59Eman M. Elsabbagh: Pediatric Nonmalignant HCT Enters the Era of Precision Conditioning and Gene Therapy
-
Sep 8, 2026, 10:50Dena Winchester: Sponsored Genetic Testing Programs Improve Access for Children With Hemophilia A
-
Sep 8, 2026, 10:49Alessandra Bosch: Von Willebrand Disease and Rare Bleeding Disorders, Collaborative Insights and Patient Empowerment
-
Sep 8, 2026, 09:42Vineet Sankhla: Rethinking Potent P2Y12 Inhibition in AF Patients Undergoing PCI
-
Sep 8, 2026, 09:23Mehdi Mirsaeidi: Platelets and Thromboinflammation in COPD
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Reading Blood Through the Peripheral Smear
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome